Allicin suppressed Escherichia coli-induced urinary tract infections by a novel MALT1/NF-κB pathway

the MALT1/NF-κB axis or AKT/NF-κB pathway, which provides a theoretical basis for understanding the function of allicin against UTIs and facilitates its clinical application.